These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3263156)

  • 41. [Activation of the complement system of plasma and the changes in various parameters of homeostasis in rats after intravenous administration of emulsion of organoperfluorine compounds].
    Dolgushina AD; Berkos MV; Piatovskaia NN; Kochetygov NI; Sedova LA
    Gematol Transfuziol; 1990 Dec; 35(12):25-6. PubMed ID: 2083830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of centrifugation leukapheresis with hydroxyethyl starch on the complement system of granulocyte donors.
    McLeod BC; Sassetti RJ
    Transfusion; 1981; 21(4):405-11. PubMed ID: 6168049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.
    Spahn DR
    Crit Care; 1999; 3(5):R93-7. PubMed ID: 11094488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Leuko- and thrombocytopenic reactions of the body to the intravenous administration of emulsions of perfluoro-organic compounds].
    Sedova LA; Berkos MV; Piatovskaia NN
    Gematol Transfuziol; 1988 Nov; 33(11):45-8. PubMed ID: 3234728
    [No Abstract]   [Full Text] [Related]  

  • 45. New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation.
    Johnson DL; Greene PS; Gott VL; Gardner TJ
    Circulation; 1988 Nov; 78(5 Pt 2):III153-7. PubMed ID: 3180395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of perfluorodecalin as an oxygen carrier on actinorhodin production by Streptomyces coelicolor A3(2).
    Elibol M; Mavituna F
    Appl Microbiol Biotechnol; 1995; 43(2):206-10. PubMed ID: 7612244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs.
    Mattrey RF; Hilpert PL; Long CD; Long DM; Mitten RM; Peterson T
    Crit Care Med; 1989 Jul; 17(7):652-6. PubMed ID: 2736927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravascular behavior of a perfluorochemical emulsion.
    Tsuda Y; Yamanouchi K; Okamoto H; Yokoyama K; Heldebrant C
    J Pharmacobiodyn; 1990 Mar; 13(3):165-71. PubMed ID: 2374085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some aspects of perfluorochemical emulsion's interaction with blood.
    Tereshina EV; Doronina NN; Afonin NI; Ozerova IN; Tcherbacova IA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1001-11. PubMed ID: 1391418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical properties of a new synthetic oxygen carrier.
    Moore RE
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):443-5. PubMed ID: 3179480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gas exchange during peritoneal perfusion with perfluorocarbon emulsions.
    Faithfull NS; Salt PJ; Klein J; van der Zee HT; Soini H; Erdmann W
    Adv Exp Med Biol; 1985; 191():463-72. PubMed ID: 3938603
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of a perfluorochemical emulsion on prednisolone binding by human albumin.
    Parsons DL
    Biochem Pharmacol; 1986 Apr; 35(8):1395-7. PubMed ID: 3964304
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
    Kerins DM
    Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
    [No Abstract]   [Full Text] [Related]  

  • 54. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second-generation perfluorocarbon emulsion blood substitutes.
    Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):25-38. PubMed ID: 10676575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of emulsions of carbon perfluoride compounds on the blood plasma complement system and functional state of the rabbit brain].
    Berkos MV; Vorob'ev VV; Piatovskaia NN; Kukushkin NI; Sedova LA
    Patol Fiziol Eksp Ter; 1991; (6):23-5. PubMed ID: 1818279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Brain electric activity of animals exposed to perfluorocarbon emulsions].
    Vorob'ev VV; Iarkov AV; Kukukshkin NI; Sologub GR; Gal'chenko AA
    Patol Fiziol Eksp Ter; 1991; (2):19-23. PubMed ID: 1881700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perfluorocarbon emulsions in cancer therapy: preliminary observations on presently available formulations.
    Goodman RL; Moore RE; Davis ME; Stokes D; Yuhas JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1421-4. PubMed ID: 6547941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood flow dependent granulocyte activation in membranes with and without complement activation.
    Böhler J; Donauer J; Schollmeyer P; Hörl WH
    Adv Exp Med Biol; 1991; 297():215-24. PubMed ID: 1767753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.